Choksi Laboratories [CHOKSILA] vs Krsnaa Diagnostics [KRSNAA] Detailed Stock Comparison
Choksi Laboratories
BSE
Loading...
Krsnaa Diagnostics
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Choksi Laboratories wins in 5 metrics, Krsnaa Diagnostics wins in 14 metrics, with 0 ties. Krsnaa Diagnostics appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Choksi Laboratories | Krsnaa Diagnostics | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 84.11 | 31.16 | Krsnaa Diagnostics |
| Price-to-Book Ratio | 5.32 | 2.78 | Krsnaa Diagnostics |
| Debt-to-Equity Ratio | 123.52 | 23.06 | Krsnaa Diagnostics |
| PEG Ratio | -10.09 | 2.16 | Choksi Laboratories |
| EV/EBITDA | 13.47 | 12.68 | Krsnaa Diagnostics |
| Profit Margin (TTM) | 3.52% | 10.84% | Krsnaa Diagnostics |
| Operating Margin (TTM) | 10.90% | 15.42% | Krsnaa Diagnostics |
| EBITDA Margin (TTM) | 10.90% | 15.42% | Krsnaa Diagnostics |
| Return on Equity | 6.45% | 8.79% | Krsnaa Diagnostics |
| Return on Assets (TTM) | 2.33% | 6.06% | Krsnaa Diagnostics |
| Free Cash Flow (TTM) | $40.91M | $-393.00M | Choksi Laboratories |
| Dividend Yield | N/A | 0.62% | N/A |
| 1-Year Return | 156.84% | -7.92% | Choksi Laboratories |
| Price-to-Sales Ratio (TTM) | 2.96 | 3.33 | Choksi Laboratories |
| Enterprise Value | $1.55B | $25.88B | Krsnaa Diagnostics |
| EV/Revenue Ratio | 3.66 | 3.50 | Krsnaa Diagnostics |
| Gross Profit Margin (TTM) | 82.45% | 67.46% | Choksi Laboratories |
| Revenue per Share (TTM) | $61 | $229 | Krsnaa Diagnostics |
| Earnings per Share (Diluted) | $2.14 | $24.36 | Krsnaa Diagnostics |
| Beta (Stock Volatility) | 0.08 | -0.18 | Krsnaa Diagnostics |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Choksi Laboratories vs Krsnaa Diagnostics Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Choksi Laboratories | 4.25% | -8.02% | -20.17% | -3.34% | 56.24% | 95.99% |
| Krsnaa Diagnostics | 4.54% | 1.05% | -6.11% | 5.04% | 6.53% | -14.59% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Choksi Laboratories | 156.84% | 352.69% | 1,519.72% | 1,273.93% | 908.86% | 301.25% |
| Krsnaa Diagnostics | -7.92% | 61.54% | -16.08% | -16.08% | -16.08% | -16.08% |
News Based Sentiment: Choksi Laboratories vs Krsnaa Diagnostics
Choksi Laboratories
News based Sentiment: MIXED
September presented a mixed bag for Choksi Laboratories, with a share price decline following the AGM offsetting positive long-term returns and a commitment to shareholder communication. The reduced trading volume suggests growing investor caution, making it a moderately significant month for investors.
Krsnaa Diagnostics
News based Sentiment: POSITIVE
Krsnaa Diagnostics reported impressive Q1 FY2025-26 results, demonstrating strong revenue and profit growth. Coupled with strategic expansion initiatives and a 'STRONG BUY' recommendation from analysts, the company appears well-positioned for continued success, making this a significant month for investors.
Performance & Financial Health Analysis: Choksi Laboratories vs Krsnaa Diagnostics
| Metric | CHOKSILA | KRSNAA |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.26B | ₹25.27B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 8,255 | 84,594 |
| 90 Day Avg. Volume | 7,354 | 59,134 |
| Last Close | ₹184.05 | ₹813.20 |
| 52 Week Range | ₹60.21 - ₹236.70 | ₹625.75 - ₹1,044.00 |
| % from 52W High | -22.24% | -22.11% |
| All-Time High | ₹236.70 (Aug 20, 2025) | ₹1,099.70 (Aug 16, 2021) |
| % from All-Time High | -22.24% | -26.05% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.05% | 0.13% |
| Quarterly Earnings Growth | -0.09% | 0.15% |
| Financial Health | ||
| Profit Margin (TTM) | 0.04% | 0.11% |
| Operating Margin (TTM) | 0.11% | 0.15% |
| Return on Equity (TTM) | 0.06% | 0.09% |
| Debt to Equity (MRQ) | 123.52 | 23.06 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹33.82 | ₹273.22 |
| Cash per Share (MRQ) | ₹0.88 | ₹21.18 |
| Operating Cash Flow (TTM) | ₹51.38M | ₹2.45M |
| Levered Free Cash Flow (TTM) | ₹15.23M | ₹776.08M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.62% |
| Last 12-Month Dividend | N/A | ₹5.25 |
Valuation & Enterprise Metrics Analysis: Choksi Laboratories vs Krsnaa Diagnostics
| Metric | CHOKSILA | KRSNAA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 84.11 | 31.16 |
| Forward P/E | N/A | 18.82 |
| PEG Ratio | -10.09 | 2.16 |
| Price to Sales (TTM) | 2.96 | 3.33 |
| Price to Book (MRQ) | 5.32 | 2.78 |
| Market Capitalization | ||
| Market Capitalization | ₹1.26B | ₹25.27B |
| Enterprise Value | ₹1.55B | ₹25.88B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.66 | 3.50 |
| Enterprise to EBITDA | 13.47 | 12.68 |
| Risk & Other Metrics | ||
| Beta | 0.08 | -0.18 |
| Book Value per Share (MRQ) | ₹33.82 | ₹273.22 |
Financial Statements Comparison: Choksi Laboratories vs Krsnaa Diagnostics
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CHOKSILA | KRSNAA |
|---|---|---|
| Revenue/Sales | ₹112.42M | ₹1.93B |
| Cost of Goods Sold | ₹19.73M | ₹627.91M |
| Gross Profit | ₹92.69M | ₹1.30B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹12.28M | ₹297.64M |
| EBITDA | ₹29.04M | ₹553.54M |
| Pre-Tax Income | ₹6.27M | ₹274.22M |
| Income Tax | ₹2.42M | ₹69.02M |
| Net Income (Profit) | ₹3.85M | ₹205.20M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CHOKSILA | KRSNAA |
|---|---|---|
| Cash & Equivalents | ₹6.12M | ₹38.46M |
| Total Current Assets | ₹163.21M | ₹4.14B |
| Total Current Liabilities | ₹238.75M | ₹3.05B |
| Long-Term Debt | ₹159.63M | ₹471.56M |
| Total Shareholders Equity | ₹236.05M | ₹8.83B |
| Retained Earnings | ₹150.56M | ₹2.00B |
| Property, Plant & Equipment | ₹471.35M | ₹256.28M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CHOKSILA | KRSNAA |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | CHOKSILA | KRSNAA |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 8,255 | 84,594 |
| Average Daily Volume (90 Day) | 7,354 | 59,134 |
| Shares Outstanding | 6.97M | 32.29M |
| Float Shares | 3.47M | 17.40M |
| % Held by Insiders | 0.59% | 0.44% |
| % Held by Institutions | 0.00% | 0.15% |
Dividend Analysis & Yield Comparison: Choksi Laboratories vs Krsnaa Diagnostics
| Metric | CHOKSILA | KRSNAA |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹5.25 |
| Last 12-Month Dividend Yield | N/A | 0.62% |
| 3-Year Avg Annual Dividend | N/A | ₹3.50 |
| 3-Year Avg Dividend Yield | N/A | 0.39% |
| 3-Year Total Dividends | N/A | ₹10.50 |
| Ex-Dividend Date | N/A | Sep 12, 2025 |